<Disease><Name>ADENOSINE DEAMINASE (ADA-SCID)</Name><Synonym>SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOS</Synonym><OMIM><Number>102700</Number><URL>http://omim.org/entry/102700</URL></OMIM><Orphanet><Number>277</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=277</URL></Orphanet><Protein><Number>adenosine deaminase</Number><URL>http://www.uniprot.org/uniprot/P00813</URL></Protein><ExPASy><Number>3.5.4.4</Number><URL>http://enzyme.expasy.org/EC/3.5.4.4</URL></ExPASy><Gene>20q13.12</Gene><ICD>D81.3</ICD><Summary>rare (1:200000 -&#160; 1:1000000);autosomal recessive;somatic mosaicism; mutation in the adenosine deaminase gene;ADA activity may be a risk factor for the development of ;autism [Bottini et al. 2001]</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3476</id><symptom>bronchiectasia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3907</id><symptom>immunodeficiency</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3913</id><symptom>infections (respiratory tract/system)</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2353</id><symptom>obstructive airway disease / asthma</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>3459</id><symptom>pulmonary alveolar proteinosis</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1646</id><name>Glutamine</name><specimen>urine</specimen><value /><min>19.10</min><max>77.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1651</id><name>Methionine</name><specimen>urine</specimen><value /><min>0.50</min><max>2.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1765</id><name>Glutamine</name><specimen>urine</specimen><value /><min>0.00</min><max>830.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1774</id><name>Methionine</name><specimen>urine</specimen><value /><min>13.00</min><max>22.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1879</id><name>Methionine</name><specimen>plasma</specimen><value /><min>16.00</min><max>23.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1880</id><name>Methionine</name><specimen>plasma</specimen><value /><min>14.00</min><max>34.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1882</id><name>Methionine</name><specimen>urine</specimen><value /><min>2.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1942</id><name>Glutamine</name><specimen>plasma</specimen><value /><min>457.00</min><max>857.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1943</id><name>Glutamine</name><specimen>plasma</specimen><value /><min>205.00</min><max>756.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1956</id><name>Methionine</name><specimen>plasma</specimen><value /><min>9.00</min><max>45.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1957</id><name>Methionine</name><specimen>plasma</specimen><value /><min>13.00</min><max>41.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1997</id><name>2-Deoxyadenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>1998</id><name>2-Deoxyadenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.70</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>1999</id><name>2-Deoxyadenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1592</id><name>Adenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>1829</id><name>Adenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>950.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>2051</id><name>Adenosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.80</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>LC-MS/MS</method><comment /></metabolite><metabolite><id>2052</id><name>Adenosine</name><specimen>urine</specimen><value>increased</value><min>0.90</min><max>2.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>15</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>52.00</min><max>205.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>858</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>45.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>14</id><name>Glutamine</name><specimen>plasma</specimen><value>increased</value><min>178.00</min><max>886.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>706</id><name>Glutamine</name><specimen>plasma</specimen><value>increased</value><min>333.00</min><max>809.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>161</id><name>L-Homocystine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>8.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>51</id><name>L-Homocystine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>5.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1906</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>63.00</min><max>229.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1907</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>112.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1908</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>76.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1770</id><name>L-Homocystine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>170.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1881</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1494</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>11.00</min><max>31.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>760</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>29.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1510</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>27.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1511</id><name>Methionine</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>29.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>699</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>11.00</min><max>30.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1161</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>10.00</min><max>60.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1162</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>11.00</min><max>31.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1288</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>6.00</min><max>46.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>1289</id><name>Methionine</name><specimen>plasma</specimen><value>increased</value><min>9.00</min><max>59.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>7073</id><title>Adenosine deaminase deficiency: a review</title><author>Flinn AM,</author><journal>Orphanet J Rare Dis</journal><year>2018</year><book /><volume>13</volume><number>1</number><pages>65</pages><co_aut>Gennery AR</co_aut></literature><literature><id>5923</id><title>A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation</title><author>Turel O,</author><journal>Pediatr Neonatol</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5924</id><title>Adenosine Deaminase Deficiency</title><author>Hershfield M</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>5970</id><title>Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases</title><author>Fumagalli M,</author><journal>Front Pharmacol</journal><year>2017</year><book /><volume>8</volume><number>0</number><pages>941</pages><co_aut>et al.</co_aut></literature><literature><id>5971</id><title>Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestation</title><author>Bradford KL,</author><journal>J Clin Immunol. 2017 Oct;37(7):626-637</journal><year>2017</year><book /><volume>37</volume><number>7</number><pages>626-637</pages><co_aut>et al.</co_aut></literature><literature><id>5972</id><title>How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID)</title><author>Kohn DB,</author><journal>J Clin Immunol</journal><year>2017</year><book /><volume>37</volume><number>4</number><pages>351-356</pages><co_aut>Gaspar HB</co_aut></literature><literature><id>5925</id><title>Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency</title><author>Whitmore KV,</author><journal>Front Immunol</journal><year>2016</year><book /><volume>7</volume><number>0</number><pages>314</pages><co_aut>Gaspar HB</co_aut></literature><literature><id>5974</id><title>Autism spectrum disorders and inborn errors of metabolism: an update</title><author>Ghaziuddin M,</author><journal>Pediatr Neurol</journal><year>2013</year><book /><volume>49</volume><number>4</number><pages>232-236</pages><co_aut>Al-Owain M</co_aut></literature><literature><id>3141</id><title>Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency</title><author>Sauer AV, Brigida I,</author><journal>Front Immunol</journal><year>2012</year><book /><volume>3</volume><number>0</number><pages>265</pages><co_aut>et al.</co_aut></literature><literature><id>3142</id><title>Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency</title><author>Kanegane H,</author><journal>Pediatr Transplant</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3143</id><title>Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis</title><author>Speckmann C,</author><journal>J Allergy Clin Immunol</journal><year>2012</year><book /><volume>130</volume><number>4</number><pages>991-994</pages><co_aut>et al.</co_aut></literature><literature><id>3144</id><title>Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis</title><author>Nakaoka H,</author><journal>Int J Hematol</journal><year>2012</year><book /><volume>95</volume><number>6</number><pages>692-696</pages><co_aut>et al.</co_aut></literature><literature><id>3145</id><title>Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency</title><author>Grunebaum E,</author><journal>J Allergy Clin Immunol</journal><year>2012</year><book /><volume>129</volume><number>6</number><pages>1588-1593</pages><co_aut>Cutz E, Roifman CM</co_aut></literature><literature><id>3146</id><title>Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency</title><author>Montiel-Equihua CA,</author><journal>Curr Gene Ther</journal><year>2012</year><book /><volume>12</volume><number>1</number><pages>57-65</pages><co_aut>Thrasher AJ, Gaspar HB</co_aut></literature><literature><id>5973</id><title>Neurological disorders of purine and pyrimidine metabolism</title><author>Micheli V,</author><journal>Curr Top Med Chem</journal><year>2011</year><book /><volume>11</volume><number>8</number><pages>923-947</pages><co_aut>et al.</co_aut></literature><literature><id>3147</id><title>How I treat ADA deficiency</title><author>Gaspar HB,</author><journal>Blood</journal><year>2009</year><book /><volume>114</volume><number>17</number><pages>3524-3532</pages><co_aut>et al.</co_aut></literature><literature><id>1576</id><title>Wnt and beta-catenin signaling target the expression of ecto-5-nucleotidase and increase extracellular adenosine generation</title><author>Spychala J</author><journal>Exp Cell Res</journal><year>2004</year><book /><volume>296</volume><number>2</number><pages>99-108</pages><co_aut>Kitajewski J</co_aut></literature><literature><id>1577</id><title>On augmentation of adenosine-mediated negative dromotropic effect by K+ released during myocardial ischemia</title><author>Juranek I</author><journal>Cent Eur J Public Health</journal><year>2004</year><book /><volume>12</volume><number>0</number><pages>33-36</pages><co_aut /></literature><literature><id>1578</id><title>Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors</title><author>Terasaka T</author><journal>J Med Chem</journal><year>2004</year><book /><volume>47</volume><number>11</number><pages>2728-2731</pages><co_aut>et al.</co_aut></literature><literature><id>1579</id><title>QSAR analysis for ADA upon interaction with a series of adenine derivatives as inhibitors</title><author>Moosavi-Movahedi AA</author><journal>Nucleosides Nucleotides Nucleic Acids</journal><year>2004</year><book /><volume>23</volume><number>3</number><pages>613-624</pages><co_aut>et al.</co_aut></literature><literature><id>1404</id><title>Gene therapy for adenosine deaminase deficiency</title><author>Aiuti A</author><journal>Curr Opin Allergy Clin Immunol</journal><year>2003</year><book /><volume>3</volume><number>6</number><pages>461-466</pages><co_aut>et al.</co_aut></literature><literature><id>1405</id><title>Genotype is an important determinant of phenotype in adenosine deaminase deficiency</title><author>Hershfield MS</author><journal>Curr Opin Immunol</journal><year>2003</year><book /><volume>15</volume><number>5</number><pages>571-577</pages><co_aut /></literature><literature><id>5975</id><title>Autism: evidence of association with adenosine deaminase genetic polymorphism</title><author>Bottini N,</author><journal>Neurogenetics</journal><year>2001</year><book /><volume>3</volume><number>2</number><pages>111-113</pages><co_aut>et al.</co_aut></literature><literature><id>1086</id><title>In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine de</title><author>Bax BE</author><journal>Br J Haematol</journal><year>2000</year><book /><volume>109</volume><number>3</number><pages>549-554</pages><co_aut>et al.</co_aut></literature><literature><id>369</id><title>Disorders of purine and pyrimidine metabolism</title><author>van den Berghe G</author><journal>in Fernandes J, Saudubray JM, Tada K (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1990</year><book /><volume>0</volume><number>0</number><pages>455-474</pages><co_aut /></literature><literature><id>3182</id><title>Handbook of 1H-NMR spectroscopy in inborn errors of metabolism: body fluid NMR spectroscopy and in vivo MR spectroscopy</title><author>Engelke UFH</author><journal>SPS</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Wevers RA</co_aut></literature></Literatures></Disease>